COVID-related mucormycosis fungal infection: The infection tends to occur more in patients who have weakened immunity from a severe disease. It doesn’t have to be left undiagnosed for long or it can lead to loss of vision, nose, jawbones, and even death.
New Delhi | Jagran News Desk: Doctors at Sir Ganga Ram Hospital in New Delhi have identified over dozen cases of mucormycosis fungal infection mainly triggered in patients who have recovered from COVID-19. According to hospital authorities, the fungal infection has a mortality of 50% – if not treated early – and leads to loss of vision, nose and jaw bones.
Infection tends to occur more in patients who have weakened immunity from a severe disease. At a time when COVID-19 infections still exceed 30K every day, it’s important to know the symptoms, causes, and treatment of the fungal infection:
What are the causes of mucormycosis fungal infection?
The ubiquitous fungus is found in the environment, although it attacks those patients cured of COVID-19 who have been given certain medications that reduce the body’s ability to fight germs, experts said, as quoted in an agency report. ANI print.
The disease can be caused by mucormycetes molds, which are found in decaying soil, leaves or woods. The fungus can enter the body through breathing, open wounds, or cuts.
The infection should not be left undiagnosed for long or it can lead to loss of vision, nose, jawbones, and even death. A person with this fungal infection generally experiences the following symptoms:
Numbness of the face
Obstruction of the nose on one side
Swelling of the eyes
You should see a doctor if you are experiencing the above symptoms after COVID recovery. A definitive diagnosis will be made by identifying the fungi in the patient’s tissue. For this, a doctor can collect a sample of your nasal discharge.
Most patients experienced significant tissue damage at the time of diagnosis. Therefore, most patients require antifungal drugs and surgical debridement.
Published by: Lakshay Raja